Halim, 2023 - Google Patents
The Exocyst Subunit EXOC2 Regulates GGGGCC Repeats Toxicity in C9ORF72-ALS/FTDHalim, 2023
View PDF- Document ID
- 16187000902952707647
- Author
- Halim D
- Publication year
External Links
Snippet
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two neurodegenerative disorders without cure. A GGGGCC repeat expansion in the first intron of C9ORF72 is the most common genetic cause of ALS and FTD. Although the mechanism of …
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sun et al. | CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage | |
Gonatopoulos-Pournatzis et al. | Autism-misregulated eIF4G microexons control synaptic translation and higher order cognitive functions | |
Caldwell et al. | Aberrant astrocyte protein secretion contributes to altered neuronal development in multiple models of neurodevelopmental disorders | |
Klim et al. | ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair | |
Phan et al. | A myelin-related transcriptomic profile is shared by Pitt–Hopkins syndrome models and human autism spectrum disorder | |
Blanco-Suarez et al. | Astrocyte-secreted chordin-like 1 drives synapse maturation and limits plasticity by increasing synaptic GluA2 AMPA receptors | |
US20230277690A1 (en) | Motor neuron-specific expression vectors | |
Valluy et al. | A coding-independent function of an alternative Ube3a transcript during neuronal development | |
Parisi et al. | MicroRNA-125b regulates microglia activation and motor neuron death in ALS | |
Zhong et al. | Upstream open reading frame with NOTCH2NLC GGC expansion generates polyglycine aggregates and disrupts nucleocytoplasmic transport: implications for polyglycine diseases | |
Li et al. | Angelman syndrome protein Ube3a regulates synaptic growth and endocytosis by inhibiting BMP signaling in Drosophila | |
CN106715695B (en) | micro-RNAs for therapy and diagnosis and compositions comprising same | |
Skariah et al. | Mov10 suppresses retroelements and regulates neuronal development and function in the developing brain | |
Bravo et al. | Human iPSC 4R tauopathy model uncovers modifiers of tau propagation | |
JP2021528445A (en) | How to treat or prevent the onset of Huntington's disease | |
Hunnicutt et al. | IKAP/Elp1 is required in vivo for neurogenesis and neuronal survival, but not for neural crest migration | |
US20240011027A1 (en) | Methods and compositions for restoring stmn2 levels | |
Liu et al. | Astrocytic response mediated by the CLU risk allele inhibits OPC proliferation and myelination in a human iPSC model | |
Li et al. | The HSA21 gene EURL/C21ORF91 controls neurogenesis within the cerebral cortex and is implicated in the pathogenesis of Down Syndrome | |
Xiong et al. | The circular RNA Edis regulates neurodevelopment and innate immunity | |
Halim | The Exocyst Subunit EXOC2 Regulates GGGGCC Repeats Toxicity in C9ORF72-ALS/FTD | |
US20240409890A1 (en) | Ufmylation inhibition to target tauopathy in human neurons | |
Blazejewski et al. | PEDF-Rpsa-Itga6 signaling regulates cortical neuronal morphogenesis | |
Renton et al. | C9ORF72 hexanucleotide repeat exerts toxicity in a stable, inducible motor neuronal cell model, which is rescued by partial depletion of Pten Matthew J. Stopford1, Adrian Higginbottom1, Guillaume M. Hautbergue1, Johnathan Cooper-Knock1, Padraig J. Mulcahy1, Kurt J. De Vos1 | |
Daswani | MIR-138 CONTROLS HIPPOCAMPAL INTERNEURON FUNCTION AND SHORT-TERM MEMORY |